Valion Bio (VBIO) Cost of Revenue (2021 - 2025)
Valion Bio (VBIO) reported Cost of Revenue of $291,000 for Q3 2025, up 254.9% from $82,000 a year earlier and up 809.4% from the prior quarter.
Powered by 
Analysis
Valion Bio (VBIO) Cost of Revenue (2021 - 2025) Analysis & Trends
Over the twelve months ended Sep 30, 2025, Valion Bio's Cost of Revenue came in at $762,000, up 7.2% year-over-year; for FY2024, it came in at $778,000, down 12.5% from FY2023.
- Cost of Revenue has a three-year compound annual growth rate of -15.6% (FY2021 to FY2024).
- By year, Cost of Revenue came in at $889,000 in FY2023 (-42.3%), $1.54 million in FY2022 (+19.0%) and $1.3 million in FY2021.
- Five-year quarterly Cost of Revenue spans a low of $20,000 in Q1 2025 and a high of $419,000 in Q4 2024.
- Year over year, Cost of Revenue gained in three of the last eight quarters, with growth averaging 4.0%.
- The high point for year-over-year Cost of Revenue in five years was Q3 2025 (growth of 254.9%); the low point was Q1 2025 (a decline of 88.0%).
- Per Business Quant data, the three quarters before Q3 2025 came in at $32,000 (Q2 2025), $20,000 (Q1 2025) and $419,000 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Valion Bio | 350,167.99 | -19.09 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 291,000.00 |
| Jun 30, 2025 | 32,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | 419,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 110,000.00 |
| Mar 31, 2024 | 167,000.00 |
| Dec 31, 2023 | 352,000.00 |
| Sep 30, 2023 | 174,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 263,000.00 |
| Dec 31, 2022 | 365,000.00 |
| Sep 30, 2022 | 414,000.00 |
| Jun 30, 2022 | 403,000.00 |
| Mar 31, 2022 | 358,000.00 |
| Dec 31, 2021 | 391,000.00 |
| Sep 30, 2021 | 303,000.00 |
| Jun 30, 2021 | 301,000.00 |
| Mar 31, 2021 | 301,000.00 |
API Access
Valion Bio Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();